Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer is a research paper published in JCI Insight (2023). On theSindex it has a DataRank of 0.663. It has been cited 82 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.663
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: P50CA097186,R01CA234715,R50CA22183,U54CA224079,P30CA015704,P01CA163227,P50CA58236,U54CA224079-05
Doris Duke Charitable Foundation
Grant: 2021184
V Foundation for Cancer Research
Grant: NA
NCI NIH HHS
Grant: P50 CA058236
NCI NIH HHS
Grant: P50 CA097186
NCI NIH HHS
Grant: U54 CA224079
NCI NIH HHS
Grant: R01 CA266452
NCI NIH HHS
Grant: R50 CA221836
NCI NIH HHS
Grant: R01 CA234715
NCI NIH HHS
Grant: P01 CA163227
NCI NIH HHS
Grant: P30 CA015704
NIH HHS
Grant: S10 OD028685
National Institutes of Health
Grant: 5R01CA266452-04
Targeting Vulnerabilities Exposed by Cancer Treatment-Induced Lineage Plasticity
National Institutes of Health
Grant: 3P50CA058236-02S1
SPECIALIZED PGM OF RESEARCH EXCELLENCE/PROSTATE CANCER
National Institutes of Health
Grant: 3P30CA015704-42S2
Cancer Center Support Grant
National Institutes of Health
Grant: 3U54CA224079-01S1
The MSKCC-UW/Fred Hutch Prostate Cancer Drug Resistance and Sensitivity Center
National Institutes of Health
Grant: 1S10OD028685-01
High-Performance Compute Cluster for Comprehensive Cancer and Infectious Diseases Research
National Institutes of Health
Grant: 5P50CA097186-13
Clinical Development of Therapeutic Strategies Targeting Damage Responses in the Prostate Tumor Microenvironment
National Institutes of Health
Grant: 6R01CA234715-03
Defining and Targeting Lineage Transition Programs Operative in AR Pathway Independent Prostate Cancer
National Institutes of Health
Grant: 5P01CA163227-09
Androgen Receptor Action in Castration Resistant Prostate Cancer
FWCI
13.73
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals